Podcasts about Morgans

The ACOG 2025 guideline specifically recommends either oral or vaginal misoprostol for cervical ripening; it does not include buccal administration among its endorsed routes. With the rising rates of both obesity and labor induction, understanding the optimal agents for induction in obese patients is crucial. In a new study released ahead of print on March 4, 2026, in the AJOG, investigators from Indianapolis released findings from a secondary analysis of the IMPROVE trial (2019, AJOG) looking at the effect of obesity on buccal vs vaginal doses of misoprostol for cervical ripening. Listen in for details.1. Haas DM, Daggy J, Flannery KM, Dorr ML, Bonsack C, Bhamidipalli SS, Pierson RC, Lathrop A, Towns R, Ngo N, Head A, Morgan S, Quinney SK. A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial. Am J Obstet Gynecol. 2019 Sep;221(3):259.e1-259.e16. doi: 10.1016/j.ajog.2019.04.037. Epub 2019 May 7. PMID: 31075246; PMCID: PMC7692024.2. ACOG July 2025: Cervical Ripening in Pregnancy, ACOG Clinical Practice Guideline No. 93. Bynarowicz, Taylor M. et al. The impact of body mass index on misoprostol dosing for labor induction: a comparison of vaginal and buccal dosage formsAmerican Journal of Obstetrics & Gynecology, Volume 0, Issue 0: https://www.ajog.org/article/S0002-9378(26)00126-2/fulltext4. Etrusco A, Sfregola G, Zendoli F, et al. Effect of Maternal Age and Body Mass Index on Induction of Labor Using Oral Misoprostol in Late-Term Pregnancies: A Retrospective Cross-Sectional Study. Gynecologic and Obstetric Investigation. 2024. 5. Prostaglandin Versus Mechanical Dilation and the Effect of Maternal Obesity on Failure to Achieve Active Labor: A Cohort Study.6. Beckwith L, Magner K, Kritzer S, Warshak CR. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2017.

All three major U.S. equity indices closed mixed on Wednesday, as a February CPI reading that came in broadly in line with expectations, together with the International Energy Agency's announcement of an emergency oil reserve release, failed to provide sufficient support to lift market sentiment.

All three (3) major stock indexes erased their earlier gains to finish mostly lower in a volatile session on Tuesday. Dow fell 34.29-points or -0.07%.

US equity markets advanced, staging an impressive intra-session rebound after President Trump reportedly viewed the war with Iran as “pretty much” done - Dow rose +239-points or +0.50%, recovering from an earlier decline of as much as -900-points. Caterpillar Inc (up +3.51%) sat at the top of the primary sector leaderboard, arresting a two-session slide that had dragged the manufacturer of construction and mining equipment down over >7%.

US equity markets retreated as oil prices continued to soar as the war between the US and Iran showed no signs of a resolution, while investors also digested the latest jobs figures - Dow fell -453-points or -0.95% paring an earlier decline of close to -950-points or ~2%. Caterpillar Inc (down -3.57%) and Nvidia Corp (-3.01%) fell over >3%. Boeing Co rallied +4.08% following a Bloomberg report that it was nearing one of the largest sales in its history, a 500-aircraft order for 737 Max planes, which would be unveiled when President Trump visits Beijing from 31 March to 2 April for his first state visit to China since 2017. "The two sides are also in talks for a widebody sale that includes about 100 Boeing 787 Dreamliner and 777X jets," the report added.

• US equity markets fell sharply as oil prices resumed their march higher after Iran claimed to have attacked a tanker in the Strait of Hormuz - Dow fell -785-points or -1.61%, having been down over >1,100 points or ~2.4% earlier in the session. Caterpillar Inc (-3.54%), Goldman Sachs Group Inc (-3.67%), Merck & Co (-3.5%), Sherwin-Williams Co (3.51%) and Walmart Inc (-3.52%) all fell 3.5%+. Salesforce Inc rallied +4.3% to be the leading performer in the 30-stock index as software stocks more broadly continued to rebound. Nvidia Corp edged +0.16% higher, recovering from an earlier decline that came Bloomberg News reported that the U.S. government is looking to add major restrictions to artificial intelligence (AI) chip exports. According to the report, U.S. officials have proposed regulations that would require U.S. companies to seek permission for all exports of AI accelerators, expanding restrictions that currently cover around 40 countries. The U.S. would only approve massive exports - such as more than 200,000 Nvidia GPUs owned by a single company - to allies that make strict security promises and “matching” investments in American AI, Bloomberg reported, citing sources. However, the proposal is not finalised and could see substantial changes.

US equity markets rallied, with unconfirmed reports that Iran has privately reached out to the US to discuss terms for ending their escalating conflict. However, Iran later denied a New York Times article that suggested operatives from its Ministry of Intelligence had reached out indirectly to the Central Intelligence Agence (CIA) with an offer to discuss terms for ending the conflict. According to Bloomberg, Iran's Tasnim News Agency cited a ministry source as saying that the New York Times report was "pure falsehood and psychological warfare" - Dow rose +238-points or +0.49%, snapping a three-session losing streak. Amazon.com Inc gained +3.88% to be the leading performer in the 30-stock index. Nvidia Corp rose +1.66%.

• US equity markets retreated but settled well off their session lows as concerns around a prolonged U.S.-Iran conflict continued to rattle investor sentiment, although comments from President Trump around ensuring energy supply helped assuage some fears - Dow fell -404-points or -0.83%, paring an earlier decline of over >1,250-points. Caterpillar Inc fell -4.03% to be the worst performer in the 30-stock index. Nvidia Corp fell -1.33% despite analysts at Morgan Stanley naming the world's most valuable company by market capitalisation as its top semiconductor pick, citing an attractive valuation. International Business Machines (IBM) Corp (up +2.47%) was the leading Dow component overnight.

US equity markets steadied, reversing steep morning session losses - Dow slipped -73-points or -0.15%, paring an earlier decline of as much as 600-points. 3M Co (down -2.33%), Home Depot Inc (-2.6%) and Procter & Gamble Co (-2.21%) all fell over >2%. Nvidia Corp rose +2.99% and was the leading performer in the 30-stock index, arresting a two-day slide that saw the chipmaking giant drop over >9.5% despite. Microsoft Corp rose +1.48%. Apple Inc (+0.20%) kicked off a three-day stretch of new product announcements overnight unveiling its new iPhone 17e and a new iPad Air, refreshing its entry-level hardware offerings with updated chips to prepare for the rollout of new artificial-intelligence (AI) features later this year.

US equity markets retreated and booked their steepest monthly declines in a year, with financial and Information technology stocks under pressure and with investors eyeing US-Iran hostilities that are poised to drive crude prices sharply higher - Dow lost 521-points or -1.05%. American Express Co (down -7.88%) and Goldman Sachs Group Inc (-7.47%) both dropped over >7%. Apple Inc fell -3.21% ahead of the company kicking off its first product launches of the year this week, culminating in a “special Apple experience" event on Wednesday night AEST (4 March). Microsoft Corp -2.24%

US equity markets weaker as a strong results from Nvidia Corp and Salesforce after the close of the previous session weren't enough to bolster the broader market - Dow inched +17-points or +0.03% higher Salesforce Inc - which has been one of the biggest victims of recent artificial intelligence (AI) disruption fears - gained +4.03% to pace gains in the 30-stock index a day after the customer service software maker reported healthy results for the fourth quarter, although its fiscal 2027 revenue forecast trailed Wall Street projections. However, Nvidia Corp shed -5.46% to book its largest single session decline since April last year despite reporting stronger-than-expected profit and revenue forecasts for the fourth quarter after the close of the previous session

• Technology stocks led US equity markets higher overnight ahead of Nvidia Corp's much anticipated quarterly result after the closing bell - Dow rose +308-points or +0.63% International Business Machines (IBM) Corp (up +3.58%) and UnitedHealth Group Inc (+3.74%) rallied over >3.5%.

• US equity markets rebounded as Technology stocks steadied after a sharp sell-off amid artificial intelligence (AI) disruption concern - Dow rose +370-points or +0.76% Salesforce Inc rose +4.07% to be the leading performer in the 30-stock index, more than recouping the previous session's -3.78% drop that came amid a broader decline on artificial intelligence (AI) disruption concerns from the likes of Anthropic. International Business Machines (IBM) Corp rose +2.67% a day after slumping -13.15%. Microsoft Corp rose +1.18%.

Submit your stock picks here: ausbiz.co/callpicks Mathan Somasundaram from Deep Data Analytics and Raymond Chan from Morgans go in-depth and stock specific on ‘the call.'BHP (BHP) Northern Star Resources (NST) Woodside (WDS) Brambles (BXB) Goodman Group (GMG) Westpac (WBC) Telstra (TLS) Wesfarmers (WES) Woolworths (WOW) CSL (CSL) Stock of the day: Reece (REH) to listen go to https://ausbiz.co/STODGet your stock pick to the front of the queue by becoming an ausbiz contributor: https://ausbiz.co/contributorsAnd we'd love it if you could leave us a review below! Hosted on Acast. See acast.com/privacy for more information.

US equity markets opened the new week on the back foot as investors digested President Trump's move to raise global tariffs and amid fresh concerns around artificial intelligence (AI) disruptions to various industries - Dow fell -822-points or -1.66%, booking its worst one-day decline since 20 January. International Business Machines (IBM) Corp slumped -13.15% and was the worst performer in the 30-stock index on concerns advances in Anthropic's AI technology could affect its business. Anthropic is slated to host an event tonight AEST to discuss the capabilities of its next generation AI assistant, Claude, and potentially announce new features. Microsoft Corp (down -3.21%) and Salesforce Inc (-3.78%) fell over >3%

U.S. equity markets advanced on Friday to cap a positive week after the Supreme Court struck down the sweeping tariffs implement implemented by the Trump administration last year.

US equity markets weaker after booking three straight sessions of gains, with oil prices climbing to six-month highs amid escalating tensions between the US and Iran - Dow fell -268-points or -0.54% Boeing Co (down -2.18%) and Sherwin-Williams Co (-2.23%) both fell over >2%.

US equity markets advanced as technology stocks found their footing and investors digested the minutes from the Federal Reserve's January monetary policy meeting - Dow rose +129-points or +0.26%, with Nvidia Corp rising +1.63% and moving back into positive territory year-to-date after Meta Platforms Inc (+0.61%) announced a new deal to buy millions of its chips as part of its data centre buildout. Meta CEO Mark Zuckerberg said in a statement that the expanded partnership continues his company's push “to deliver personal superintelligence to everyone in the world,” a vision he announced in July. Financial terms of the deal were not provided. Amazon.com Inc rose +1.81% despite Berkshire Hathaway reporting via a 13F filing that it had sold nearly all of its stake in the e-commerce giant. Analysts at Morgan Stanley regard Amazon as a “top pick” and both Amazon Web Services and the company's retail business are shaping up to be massive beneficiaries of the artificial intelligence (AI) wave Amgen Inc (+1.71%), Chevron Corp (+1.84%), Cisco Systems Inc (+1.73%), Salesforce Inc (+1.90%) and Walt Disney Co (+1.57%) all gained over >1.5%. 3M Co (down 2.06%) and Boeing Co (-2.09%) fell over >2%

US equity markets little changed after resuming trading following the President's Day long weekend and after booked their worst weekly declines of 206 to date last week - Dow rose +32-points or +0.07% Apple Inc (up +3.17%) was the leading performer in the 30 stock index and paced gains in the ‘Magnificent Seven' cohort of mega-capitalisation technology stocks a day after announced it will hold a product launch event on 4 March, with the newest iPhone, a low-cost MacBook, and a faster iPad expected to be among the products featured. American Express Co and Nike Inc rose over >2%. Walmart Inc (down -3.76%) was the worst performing Dow component overnight, with the retail giant slated to release its fourth quarter result on Thursday night AEST (19 February).

US equity and bond markets were CLOSED overnight for Presidents Day.

US equity markets settled little changed, losing steam in the final hour of Friday's (13 February) - Dow eased -49-points or +0.10% Visa Inc (down -3.12%), while ‘Magnificent Seven' mega-capitalisation technology stocks Apple Inc (-2.24%) and Nvidia Corp (-2.21%) fell over >2%. Nike Inc (+3.32%) and UnitedHealth Group Inc (+3.1%) climbed over >3%, Cisco Systems Inc (+2.47%) and Salesforce Inc (+2.31%) gained over >2%.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027.Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027.Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027.Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027.Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027.Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027.Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc.Disclosure information is available at the beginning of the video presentation.

US equity markets declined sharply as investors continued to rotate out of technology stocks while mulling the latest economic data and corporate earnings releases - Dow -669-points or -1.34% Cisco Systems Inc tumbled -12.32%, booking its worst single session decline since 2022 and the worst performer in the 30-stock index following the release of the networking giant's fourth quarter result after the close of the previous session that recorded a decline gross margins as memory costs surged. Apple Inc (-5%, wiping ~US$202B off the company in market capitalisation terms) and Walt Disney Co (-5.31%) lost -5%+, while International Business Machines (IBM) Corp (-4.87%) and Goldman Sachs Group Inc (-4.24%) both fell over >4%. McDonalds Corp +2.74% Walmart Inc +3.78%

Rebautizados en 2023 como "Casino Montreal" -en su anterior etapa artística se denominaban "The Morgans"-, este trío ponferradino de indie rock arranca el año presentando nuevas canciones y dando continuidad al goteo de estrenos que también salpicó musicalmente su 2025. En compañía de Kike Cardiaco, escuchamos parte de su material más reciente, que, presumiblemente, formará parte del que está llamado a ser su segundo disco, después de haber publicado hace ya tres años su debut, "El hombre excepcional".

US equity markets retreated as investors digested stronger-than-expected jobs data and as software stocks came under fresh selling pressure - Dow eased -67-points or -0.13%, snapping a three-session losing streak. International Business Machines (IBM) Corp dropped -6.5%, while American Express Co (-2.53%) and Boeing Co (2.61%) fell over >2.5%. Caterpillar Inc (4.4%) and Verizon Communications Inc (3.33%) were the leading components in the 30-stock index, while Coca-Cola Co (+2.33%) rebounded a day after posting weaker-than-expected revenue for the fourth quarter

US equity markets retreated as investors digested weaker-than-expected retails sales figures and turned their attention to the potential threat artificial intelligence (AI) poses to the financial sector - Dow added +52-points or +0.10% to 50,188.14, booking its third consecutive record closing and intra-day high after climbing above the >50,000 level last Friday (6 February). Home Depot Inc (up +2.28%) and Walt Disney Co (+2.64%) both gained over >2%.

US equity markets advanced after posting a sharp rebound last Friday (6 February), with technology again leading the gains - Dow inched +20-points or +0.04% higher to a fresh record closing high of 50,135.87 a day after the 30-stock index has climbed above the 50,000 level for the first time. Microsoft Corp (up +3.05%) was the leading Dow component, while Caterpillar Inc (+2.19%), Cisco Systems Inc (2.31%) and Nvidia Corp (2.5%) all climbed over >2%. Merck & Co Inc fell -3.51%, while Travelers Companies Inc (down -2.88%), Nike Inc (-2.36%) and Amgen Inc (-2.21%) all fell over >2%.

US equity markets rebounded sharply as technology stocks rallied following a wave of selling in recent sessions - Dow jumped +1,207-points or +2.47% to a record closing high of 50,115.67, the first time the 30-stock index has climbed above the 50,000 mark. Nvidia Corp +7.87%, with Chief Executive Officer (CEO) Jensen Huang saying in a televised interview with CNBC that demand has been "going through the roof" as cloud heavyweights lead what he believes could become the “largest infrastructure buildout in human history.” Caterpillar Inc +7.07%. However, Amazon.com Inc fell -5.55% after the company forecast a more than 50% jump in capital expenditures this year as part of its fourth quarter result released after the close of the previous session, intensifying the AI-driven spending spree already underway among its "Magnificent Seven" mega-capitalisation peers.

US equity indices declined as a "risk-off" selloff spared few corners of the market and with losses acerating in the closing hour of trading - Dow -593-points or -1.20% Microsoft Corp (down -4.97% and now down over >27% from its 28 October peak) and Salesforce Inc (-4.75%) both fell over >4.5%, while investment banks Goldman Sach Group Inc (-2.51%) and JPMorgan Chase & Co (-2.24%) fell over >2%.

US equity markets retreated as the sell-off in technology stocks intensified - Dow rose +260-points or +0.53%, with Amgen Inc jumping +8.15% to be the leading performer in the 30-stock index after the biopharmaceutical company reported a better-than-expected fourth result after the close of the previous session. Nike Inc (up +5.4%) and 3M Co (+5.21%) both climbed over >5%. ‘Magnificent Seven' mega-capitalisation technology names Nvidia Corp (down -3.41%) and Amazon.com Inc (-2.36%) were under pressure, along with technology peers Cisco Systems Inc (-2.35%) and International Business Machines (IBM) Corp (-1.79%

Technology stocks came under renewed selling pressure, dragging US equity markets lower - Dow fell -167-points or -0.34% to 49,240.99 after touching a record intra-day high of 49,653.13. Nvidia Corp fell -2.87%, with Chief Executive Officer (CEO) Jensen Huang saying in an interview with CNBC that the chipmaker's plan to invest in OpenAI remains “on track” after recent reports suggested brewing tension between the two sides. Mr Huang said that Nvidia would invest in OpenAI's next fundraising round, which he called the “largest private round ever raised in history.” OpenAI is engaging in fundraising discussions for a round that could raise as much as US$100B, according to a CNBC report last month. Retail giant Walmart Inc rose +2.94% and joined the club of stocks with a market capitalisation more than US$1 trillion. Only 11 other companies are larger, with Nvidia and Alphabet Inc (-1.22%) having market capitalisations greater than >US$4 trillion.

US equity markets opened February on a firmer footing despite fresh falls on metals markets and as investors continued to ponder President Trump's nomination for the next Chair of the Federal Reserve - Dow rose +515-points or +1.05%. Caterpillar Inc (+5.1%), Walmart Inc (+4.13%) and Apple Inc (4.06%) all rallied over >4%. Nvidia Corp dropped -2.89% after The Wall Street Journal (WSJ), citing people familiar with the matter, that the chipmaking giant's plans to pour US$100B into OpenAI had stalled, with company executives expressing doubt about the deal.

US equity markets retreated on Friday (30 January) as technology stocks remained under pressure, while precious metals markets saw some vicious volatility - Dow fell -179-points or -0.36% as a host of components in the 30-stock index posted quarterly results.

SBS Finance Editor Ricardo Gonçalves speaks with Canstar's Sally Tindall to find out if it is too late to fix your home loan interest rate ahead of what's expected to be a rise in official interest rates next week; plus Dianne Colledge from Morgans goes through the day's share market action including a preview of Donald Trump's pick of US Federal Reserve governor which is expected to be made at the weekend.

SBS Finance Editor Ricardo Gonçalves speaks with Canstar's Sally Tindall to find out if it is too late to fix your home loan interest rate ahead of what's expected to be a rise in official interest rates next week; plus Dianne Colledge from Morgans goes through the day's share market action including a preview of Donald Trump's pick of US Federal Reserve governor which is expected to be made at the weekend.

• US equity markets settled narrowly mixed as investors absorbed another busy corporate earnings calendar - Dow edged +56-points or +0.11% higher, with International Business Machines Corp (IBM) rising +5.13% to be the leading performer in the 30-stock index after posting stronger-than-expected fourth quarter EPS and revenue after the close of the previous session. Microsoft Corp tumbled -9.99% and recorded worst daily performance since March 2020 following the release of the company's fourth quarter result after the close of the previous session, with investors seemingly unnerved by record spending on artificial intelligence (AI) last quarter.

Kudos to Phillip Mills. He of the gym empire and, as it turns out, this election year's star turn in the donation department. His money for the Opportunity Party is the first large declared donation. I like it for a couple of reasons. Business owners and leaders too often display a fear when it comes to views and support and commentary. I learned it sadly during Covid. The anger privately never matched the anger publicly from some of the nation's biggest names and businesses, because they feared retribution from the Government of the day. Mills, like any owner, especially in this day and age, risks pushback from a public he wants to give him money to turn up at his place to pump iron. It's way easier to keep your head down, so good on him. Sadly, he has wasted his money. But that is the beauty of election year and democracy – we are all free to do the same. TOP will not make it the way Mills thinks they will. Personally, I kind of hope I'm wrong. The whole MMP “thing” was about greater representation and if TOP cracked it, I would be pleased to see another player. Sadly, it is not to be because TOP are too nuanced and there is no obvious gap to fill. They are the middle of the road music station looking to find a spot between the Hits, Coast, and the Breeze. Except unlike radio where entry is free, in politics you need 5%, and 5% is a lot. As I have said before, the Gareth Morgan era was their opening. The easier route is an electorate with plenty of choice already, get a high profile player like Morgan, split the vote, win the seat and the coattail at about 2% might get you not one, but two MPs. They have no Morgans. Even Raf Manji, who ran in Christchurch last time and had some profile, didn't do it. So as we sit here this morning, dollars to donuts, you can't even name the leader or any member of the party. And as for their polices, they are a mix of obscure and overlap. In other words, a lot of what they think is already in the Parliament if that's what you want. In simple terms, our Parliament is full. Six parties are all we want. Phillip has $50,000 that says I'm wrong. But of all the predictions I will make this year, this is right up there on the confidence scale. See omnystudio.com/listener for privacy information.

Kev Morgans is a multi-award-winning wildlife photographer, guide, and conservation storyteller specialising in the seabirds and wild coastlines of the British Isles. Best known for his work with Atlantic puffins and his book Puffins: Life on the Atlantic Edge, Kev uses powerful imagery to inspire connection, awareness, and protection of the natural world.

PopaHALLics #157 "Ho Ho Pop"On our last episode of 2025, we discuss new movies including the latest "Knives Out" and "Hamnet," and books including a great take on the Lennon-McCartney relationship. Plus Kate looks back at "Buffy the Vampire Slayer"!In Theaters:"Hamnet." Academy-Award winning director Chloe Zhao and author Maggie O'Farrell explore how the loss of a son inspires William Shakespeare's "Hamlet." Starring Jessie Buckley and Paul Mescal.Streaming: "Wake up Dead Man: A Knives Out Mystery," Netflix. In the third installment of Rian Johnson's detective series, Benoit Blanc (Daniel Craig, in thumbnail photo) investigates a murder mystery "with biblical proportions" in a small town. With Josh O'Connor, Josh Brolin, and Glenn Close."The Family Plan 2," Apple TV. In this action comedy sequel, the Morgans' trip to London at Christmas is complicated by a "ghost from the past." Starring Mark Wahlberg, Michelle Monaghan, and Kit Harrington ("Game of Thrones")."Buffy the Vampire Slayer," Hulu. Buffy (Sarah Michelle Gellar) and her friends (including Alyson Hannigan and Nicholas Brendon) battle vampires and the terrors of high school in this series (1997-2003).Books:"John & Paul: A Love Story in Song," by Ian Leslie. This fresh take on the Beatles examines Lennon and McCartney's relationship from 1957 to 1980 through songs, both their favorites and their originals."Brightly Shining," by Ingvild H. Rishøi. Two young sisters struggle to make a Christmas for themselves as their father struggles with unemployment and alcoholism."Mr. Splitfoot," by Samantha Harris. This contemporary gothic novel interweaves two timelines, one about two orphans in the 1980s and the other about a mysterious walking pilgrimage decades later.The "fair use" doctrine of U.S. copyright law allows for limited unauthorized use of copyrighted material for purposes such as comment and education.

Families at War are Peak Comedy This week on the podcast, Brian and Darryl are reviewing two very different family movies… one where the whole family works to fight the “King of the North”. The other was an all-out brawl with Mom and Dad for all the flowers. Episode Index Intro: 0:07 The Family Plan 2: 6:15 The Roses: 15:29 The Family Plan 2 (Apple TV) Rating Out of 10 Short Haired Jon Snow Looks Really Weird Darryl: 4.5/10 Brian: 5.1/10 Summary The Family Plan 2 picks up three years after the first film. Dan Morgan has left car sales behind and now runs a private security firm, trying to balance normal dad life with a past as elite assassin Sean McCaffrey that will not stay buried. When the family travels to London to visit daughter Nina, Dan's “routine” security assessment at a bank goes sideways. He discovers the client, Finn Clarke, is actually his half-brother, tied to his father's criminal network, and is using Dan to pull off a high-tech heist. The Morgans get caught between assassins, Interpol-level stakes, and messy family drama that stretches from London to Paris while they try to stay alive and stay a family. Main Cast – The Family Plan 2 Mark Wahlberg – Dan Morgan / Sean McCaffrey, ex-assassin dad now running a security firm Michelle Monaghan – Jessica Morgan, his wife and former decathlete turned coach Zoe Colletti – Nina Morgan, their oldest child, studying abroad in London Van Crosby – Kyle Morgan, gamer son with niche fame as “Kylleboi” Peter and Theodore Lindsey – Max Morgan, youngest son Kit Harington – Finn Clarke, Dan's half-brother and main antagonist Sidse Babett Knudsen – Svetlana Romanova, Dan's former Russian intelligence contact Sanjeev Bhaskar – Vikram, a former butler who sides with Dan Reda Elazouar – Omar, Nina's boyfriend, with a very useful dad Daniel de Bourg – Jules The Roses (2025) Rating Out of 10 What Happens When Mom and Dad Go Mental Darryl: 6.69/10 Brian: 6.3/10 Summary A reimagining of The War of the Roses, The Roses is a satirical black comedy about Ivy and Theo Rose, a seemingly perfect married couple with great careers, kids, and a dream life that slowly curdles into open warfare. As Ivy's restaurant empire takes off and Theo's architecture career collapses, resentment builds. What starts as quiet competition turns into a full-blown psychological and physical battle inside their custom dream house, with friends, lawyers, therapists, and staff getting pulled into the escalating chaos. Main Cast Benedict Cumberbatch – Theo Rose, architect and husband Olivia Colman – Ivy Rose, rising restaurateur and wife Hala Finley – Hattie Rose (with Delaney Quinn as young Hattie) Wells Rappaport – Roy Rose (with Ollie Robinson as young Roy) Andy Samberg – Barry, friend and later Theo's divorce lawyer Kate McKinnon – Amy, Barry's wife and friend of the Roses Ncuti Gatwa – Jeffrey, front of house manager at Ivy's restaurant Sunita Mani – Jane, Ivy's sous chef Zoë Chao – Sally, friend, married to Rory Jamie Demetriou – Rory, friend, married to Sally Allison Janney – Eleanor, Ivy's divorce lawyer Belinda Bromilow – Janice, their marriage counselor Contact Us The Infamous Podcast can be found wherever podcasts are found on the Interwebs, feel free to subscribe and follow along on social media. And don't be shy about helping out the show with a 5-star review on Apple Podcasts to help us move up in the ratings. @infamouspodcast facebook/infamouspodcast instagram/infamouspodcast stitcher Apple Podcasts Spotify Google Play iHeart Radio contact@infamouspodcast.com Our theme music is ‘Skate Beat’ provided by Michael Henry, with additional music provided by Michael Henry. Find more at MeetMichaelHenry.com. The Infamous Podcast is hosted by Brian Tudor and Darryl Jasper, is recorded in Cincinnati, Ohio. The show is produced and edited by Brian Tudor. Subscribe today!

This week on Talking Wealth, Janine challenges the forecast set for CBA shares by Morgans and other major institutions - how low could this ASX banking giant really go? Janine examines the chart of CBA to determine whether these bearish predictions are genuine warnings or exaggerated calls designed to spark panic selling and boost broker profits? Where is the current fall likely to stop?

New details emerge about the coordinated attack on bitcoin!!► Bitcoin Well: https://www.nmj1gs2i.com/63CFP/FGXLG/?source_id=podcast► Ledn: https://www.nmj1gs2i.com/63CFP/9B9DM/?source_id=podcastSimply Bitcoin clients get 0.25% off their first loan► Bitkey: https://www.nmj1gs2i.com/63CFP/7XDN2/?source_id=podcastSIMPLY for 20%► SAT123: https://www.nmj1gs2i.com/63CFP/KMKS9/?source_id=podcastUse code SIMPLY for 15% off► Stamp Seed: https://www.nmj1gs2i.com/63CFP/M2GJW/?source_id=podcastPROMO CODE: SIMPLY for a 15% discount► HIVE Digital Technologies: https://www.nmj1gs2i.com/63CFP/6JHXF/?source_id=podcast► BitcoinBen: bitcoinben.ioFOLLOW US► https://twitter.com/SimplyBitcoinTV► https://twitter.com/bitvolt► https://twitter.com/Optimistfields► Nostr: npub1vzjukpr2vrxqg2m9q3a996gpzx8qktg82vnl9jlxp7a9yawnwxfsqnx9gcJOIN OUR TELEGRAM, GIVE US A MEME TO REVIEW!► https://t.me/SimplyBitcoinTVSUBSCRIBE TO OUR YOUTUBE► https://bit.ly/3QbgqTQSUPPORT US► On-Chain: bc1qpm5j7wsnk46l2ukgpm7w3deesx2mdrzcgun6ms► Lightning: simplybitcoin@walletofsatoshi.com#bitcoin #bitcoinnews #simplybitcoinDISCLAIMER: All views in this episode are our own and DO NOT reflect the views of any of our guests or sponsors.Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, education and research. If you are or represent the copyright owner of materials used in this video and have a problem with the use of said material, please contact Simply Bitcoin.

For the Morgans, being a bank robber ran in the family. Doug and his twin brother Peter robbed more than 20 banks in their criminal careers, following in the footsteps of their father. Doug joins Gary Jubelin to reveal what life was really like as a bank robber, his biggest haul and how he became one of the most wanted men in Australia. Want to hear more from I Catch Killers? Visit news.com.au. Watch episodes of I Catch Killers on our YouTube channel here. Like the show? Get more at icatchkillers.com.au Advertising enquiries: newspodcastssold@news.com.au Questions for Gary: icatchkillers@news.com.au Get in touch with the show by joining our Facebook group, and visiting us on Instagram or Tiktok.See omnystudio.com/listener for privacy information.

Today's guest is Ian Schrager, the legendary hotelier, entrepreneur, and cultural pioneer who reshaped nightlife and hospitality as we know it.Ian first made his mark in the 1970s as the co-founder of Studio 54, the iconic New York nightclub that became a symbol of glamour, freedom, and cultural revolution. Alongside his partner Steve Rubell, Ian created an experience that transcended nightlife, merging design, celebrity, and theatricality into something entirely new.After Studio 54, Ian continued to reinvent hospitality. In the 1980s, he launched the Morgans Hotel Group, introducing the world's first “boutique hotel” : a concept that blended art, design, and service in a way that changed the industry forever. At a time when hotels were seen purely as places to sleep, Ian reimagined them as vibrant social hubs, activating lobbies, bars, and restaurants as dynamic public spaces that reflected and contributed to the cultural life of a city. With properties like Morgans, the Royalton, and the Delano, he transformed the hotel from a travel necessity into a cornerstone of the modern urban landscape: a place where design, community, and experience converged.In more recent years, Ian has continued to redefine hospitality with two visionary brands. EDITION Hotels, created in partnership with Marriott International, brings his boutique sensibility to a global stage. With around 22 properties worldwide, from New York and Miami Beach to London, Barcelona, Tokyo, and Dubai, each EDITION is designed as a one-of-a-kind reflection of its city, combining understated luxury, cutting-edge design, and activated social spaces that feel both intimate and electric.By contrast, PUBLIC represents Ian's evolution of the idea: “luxury for all.” Its flagship on New York's Lower East Side, designed by Herzog & de Meuron, reimagines the hotel experience through high style, technology, and inclusivity, featuring self check-in, vibrant communal areas, and nightlife-driven energy at a democratic price point. With plans to expand to West Hollywood and beyond, PUBLIC distills Schrager's decades of innovation into an accessible, modern model for the next generation of travelers.Across every chapter of his career, Ian Schrager has consistently challenged convention, blurring the lines between hospitality, art, and lifestyle, and influencing generations of hoteliers, designers, and creatives along the way.In this episode, Ian reflects on his incredible journey, from Studio 54 to the present, and shares the insights, risks, and instincts that have defined his enduring legacy.A heartfelt thank you to Peoplevine for sponsoring The Stanza podcast this year (and for supporting The Stanza since the beginning). If you run a members club or a hotel that needs a CRM for top performance, Peoplevine is trusted by the best brands in the members club business. Book a free demo to see why at ⁠peoplevine.com.⁠Interview Highlights:How Ian Schrager brought the lessons of Studio 54 into hospitalityTurning hotel lobbies into social and cultural spacesThe $60,000 deal that led to his first hotel, MorgansWhat “boutique hotel” really meant in its original formIan's perspective on copycatsHow creativity and independence can survive inside big hotel brandsRedefining luxury as an experience, not a price pointIan's advice for young hoteliersFollow Ian on⁠ Instagram⁠Follow Public Hotels and Edition HotelsFollow The Stanza on ⁠⁠Instagram⁠⁠

On this episode, Curtis May welcomes Brent Kesler, a former chiropractor who transformed his life by applying a 200-year-old wealth strategy once used by the Rockefellers and Morgans. After eliminating nearly $1 million in debt in just 39 months, Brent sold his five successful chiropractic clinics to dedicate himself fully to wealth education. Today, as the founder of The Money Multiplier, Brent has taught more than 17,000 people how to build generational wealth outside of Wall Street's traps. His own daughter became a millionaire by age 24 using these very principles. Highlights What You'll Learn: -How the Money Multiplier Method helps families transform their financial future -Why Brent believes 401(k)s are outdated and dangerous -How to accelerate debt freedom and build a private family banking system -Case studies from everyday people who've created generational wealth -The role of financial literacy in preparing the next generation   Key Takeaway: You don't need to start wealthy to build wealth. With the right system, you can eliminate debt, stop losing money to banks and Wall Street, and take control of your financial future.   Links and Resources from this Episode https://www.practicalwealthadvisors.com https://www.practicalwealthsolutions.net/ Email Curtis for a free report - curtmay@gmail.com  Call his office - 610-622-3121 ERC Tax Credit - https://ercspecialists.com?fpr=curtis75 Schedule a call with Curtis: https://aptwithcurtis.as.me/Strategysession CashFlow Mapping: https://practicalwealth.cashflowmapping.com/lp/PWbudgetsstink  Take the Next Step with Curtis May: Business Owners: Assess Your Challenges with Cash Flow → https://curtis-73no5r8j.scoreapp.com  Private Banking Readiness Assessment → https://curtis-qljorw8q.scoreapp.com  How Ready Are You to Be Your Own Bank? → https://link.agent-crm.com/widget/quiz/XJwH7kM0wWxYB1KICcOW  Connect with Brent Kesler & The Money Multiplier: Instagram: @the.money.multiplier  brent@themoneymultiplier.com  Facebook: The Money Multiplier LinkedIn: Brent Kesler Website: themoneymultiplier.com  Linktree: linktr.ee/themoneymultiplier  Special Listener Gift Schedule a 15-Minute Call with Curtis: https://aptwithcurtis.as.me/Strategysession   Review, Subscribe and Share If you like what you hear please leave a review by clicking here   Make sure you're subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts  Click here to subscribe with Spotify Click here to subscribe with RSS